Institute of Applied Synthetic Chemistry, TU Wien, Getreidemarkt 9/163, 1060, Vienna, Austria.
X-ray Center, TU Wien, Getreidemarkt 9/164, 1060, Vienna, Austria.
Chemistry. 2023 Jan 12;29(3):e202203069. doi: 10.1002/chem.202203069. Epub 2022 Nov 24.
Modified trans-cyclooctenes (TCO) are capable of highly efficient molecular manipulations in biological environments, driven by the bioorthogonal reaction with tetrazines (Tz). The development of click-cleavable TCO has fueled the field of in vivo chemistry and enabled the design of therapeutic strategies that have already started to enter the clinic. A key element for most of these approaches is the implementation of a cleavable TCO linker. So far, only one member of this class has been developed, a compound that requires a high synthetic effort, mainly to fulfill the multilayered demands on its chemical structure. To tackle this limitation, we developed a dioxolane-fused cleavable TCO linker (dcTCO) that can be prepared in only five steps by applying an oxidative desymmetrization to achieve diastereoselective introduction of the required functionalities. Based on investigation of the structure, reaction kinetics, stability, and hydrophilicity of dcTCO, we demonstrate its bioorthogonal application in the design of a caged prodrug that can be activated by in-situ Tz-triggered cleavage to achieve a remarkable >1000-fold increase in cytotoxicity.
修饰后的环辛烯(TCO)能够在生物环境中通过与四嗪(Tz)的生物正交反应进行高效的分子操作。点击可裂解 TCO 的开发推动了体内化学领域的发展,并能够设计出已经开始进入临床阶段的治疗策略。这些方法中的大多数关键要素是使用可裂解的 TCO 接头。到目前为止,仅开发了此类化合物中的一个成员,该化合物需要大量的合成工作,主要是为了满足其化学结构的多层次需求。为了解决这一限制,我们开发了一种二氧戊环融合的可裂解 TCO 接头(dcTCO),仅通过应用氧化去对称化反应即可在五步内制备,从而实现所需功能的非对映选择性引入。基于对 dcTCO 的结构、反应动力学、稳定性和亲水性的研究,我们证明了它在设计笼状前药中的生物正交应用,该前药可以通过原位 Tz 触发裂解激活,从而使细胞毒性显著增加>1000 倍。